Core Scientific, Inc./tx (CORZZ) stock
CORZZNasdaqFinance ServicesFiscal year ends December 31Also trades as CORZ, CORZR, CORZW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 2/30223% above fair value
$12.85−1.46 (-10.20%)
Close on Oct 30, 2026Market cap $4.13BP/E –Yield –
Core Scientific revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Core Scientific's revenue for the twelve months ending Jun 30, 2026 was $440.31M, up 26.4% year over year. For fiscal 2025 it was $319.02M, down 37.5% from the year before. The highest annual figure on record is $640.31M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $319.02M | -37.5% |
| FY2024 | Dec 31, 2024 | $510.67M | +1.6% |
| FY2023 | Dec 31, 2023 | $502.40M | -21.5% |
| FY2022 | Dec 31, 2022 | $640.31M | +17.6% |
| FY2021 | Dec 31, 2021 | $544.48M | +802.7% |
| FY2020 | Dec 31, 2020 | $60.32M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $164.20M | +108.8% |
| Q1 FY2026 | Mar 31, 2026 | $115.24M | +44.9% |
| Q4 FY2025 | Dec 31, 2025 | $79.76M | -16.0% |
| Q3 FY2025 | Sep 30, 2025 | $81.10M | -14.9% |
| Q2 FY2025 | Jun 30, 2025 | $78.63M | -44.3% |
| Q1 FY2025 | Mar 31, 2025 | $79.53M | -55.6% |
| Q4 FY2024 | Dec 31, 2024 | $94.93M | -33.1% |
| Q3 FY2024 | Sep 30, 2024 | $95.35M | -15.5% |
| Q2 FY2024 | Jun 30, 2024 | $141.10M | +11.2% |
| Q1 FY2024 | Mar 31, 2024 | $179.29M | +48.6% |
| Q4 FY2023 | Dec 31, 2023 | $141.93M | +17.1% |
| Q3 FY2023 | Sep 30, 2023 | $112.90M | -30.6% |
| Q2 FY2023 | Jun 30, 2023 | $126.91M | -22.6% |
| Q1 FY2023 | Mar 31, 2023 | $120.66M | -37.3% |
| Q4 FY2022 | Dec 31, 2022 | $121.25M | -59.8% |
| Q3 FY2022 | Sep 30, 2022 | $162.57M | +43.7% |
| Q2 FY2022 | Jun 30, 2022 | $163.97M | +117.7% |
| Q1 FY2022 | Mar 31, 2022 | $192.52M | +254.9% |
| Q4 FY2021 | Dec 31, 2021 | $301.80M | – |
| Q3 FY2021 | Sep 30, 2021 | $113.14M | – |
| Q2 FY2021 | Jun 30, 2021 | $75.30M | – |
| Q1 FY2021 | Mar 31, 2021 | $54.25M | – |